NCT01338870
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Roseville, California, United States
- Pfizer Investigational Site Denver, Colorado, United States
- Pfizer Investigational Site Coral Gables, Florida, United States